XML 107 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Contingent consideration, beginning balance $ 456 $ 777
Changes in estimated fair value 15 (146)
Payments (117) (119)
Other 0 (56)
Contingent consideration, ending balance 354 456
Contingent consideration, liability, current 128  
Sanofi Pasteur    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Contingent consideration, beginning balance 368  
Contingent consideration, ending balance $ 263 $ 368
Contingent consideration, measurement input, discount rate 0.115